Monograph Details
|
|
Central Nervous System
> ADHD/narcolepsy
|
|
RITALIN-SR |
| Manufacturer |
|
Novartis Pharmaceuticals Corp |
| Legal Classification |
|
CII |
| Generic Name |
|
Methylphenidate HCl 20mg; sust-rel tabs; dye free. |
| Also |
• RITALIN
• RITALIN LA
|
| Indications |
|
Attention deficit hyperactivity disorder. Narcolepsy. |
| Adults and Children |
|
Swallow whole. May use Ritalin-SR tabs in place of Ritalin tabs when the 8-hr dose of Ritalin-SR corresponds to the titrated 8-hr dose of Ritalin. Max 60mg/day. |
| Contraindications |
|
Marked anxiety, tension, agitation. Glaucoma. History of tics or Tourette's syndrome in patient or family. During or within 14 days of MAOIs. |
| Precautions |
|
Discontinue if seizures or agitation occur. Reduce dose or discontinue if paradoxical worsening of symptoms occurs. Reassess periodically. Reevaluate therapy at puberty. Hypertension. Psychosis. Seizure disorders. Depression. Normal fatigue states. Emotionally unstable (eg, drug or alcohol abusers). May exacerbate behavior disturbances, thought disorders. Monitor growth, BP, CBC, differential, platelet counts. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
See Contraindications. Caution with pressor agents, α2-agonists (eg, clonidine). May increase levels of anticonvulsants, oral anticoagulants, tricyclics, phenylbutazone. Antagonizes guanethidine, other antihypertensives. Drugs that affect GI pH may affect release of methylphenidate from caps. |
| Adverse Reactions |
|
Insomnia, nervousness, CNS overstimulation, anorexia, weight loss, abdominal pain, nausea, dizziness, headache, dyskinesias, hypertension, tachycardia, arrhythmias, Tourette's syndrome, toxic psychosis, seizures, blood dyscrasias, rash, visual disturbances. |
| How Supplied |
|
All—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
